Laboratory of Pharmacology, Université Libre de Bruxelles,
Bruxelles, Belgium (R.O., Q.-A.N., M.-H.A., P.L.);
Department of
Pharmacy, Université de Namur, Namur, Belgium (L.P., B.M.); and
Department of Biomedical Science, The University of Sheffield,
Sheffield, United Kingdom (C.K., M.J.D.)
 |
Introduction |
The
cyanoguanidine and the 1,1-diamino-2-nitroethylene functions are
considered bioisosteres of the urea and thiourea functions (Thornber,
1979
). The substitution of the thiourea moiety of metiamide, initially
developed as H2 receptor antagonist, or the substitution of
the urea group of its derivatives by a cyanoguanidine or a 1,1-diamino-2 nitroethylene function led to the discovery of powerful inhibitors of gastric acid secretion such as cimetidine (Durant et al.,
1977
) and ranitidine (Brodgen et al., 1979
), respectively. The latter
compounds exhibited a higher H2-blocking activity than the
parent molecule metiamide. The inverse strategy was conducted from
pinacidil, an antihypertensive cyanoguanidine, and generated thioureas
as potent as pinacidil on vascular smooth muscle (Manley and Quast,
1992
). Moreover, the cyanoguanidine bioisosteres of phenytoin, an
antiepileptic acylurea, and torasemide, a diuretic sulfonylurea, have
also been prepared (Masereel et al., 1995
; Lambert et al., 1996
). These
compounds, unfortunately, appeared to be less active than their parent
molecules (Masereel et al., 1995
; Lambert et al., 1996
).
In an attempt to improve the potency of hypoglycemic sulfonylureas, we
recently applied a similar strategy by replacing their urea function
with a sulfonylcyanoguanidine or a sulfonamidonitroethylene (Masereel et al., 1996
, 1997
). Among the different compounds
synthesized, two isosteres of glibenclamide (Fig.
1); namely, BM 208 (N-[4-(5-chloro2-methoxybenzamidoethyl)benzenesulfonyl]-N'-cyano-N"-cyclohexylguanidine) and BM 225 (1-[4-(5-chloro-2-methoxybenzamidoethyl)benzenesulfonamido]-1-cyclohexylamino-2-nitroethylene), stimulated insulin release from incubated rat pancreatic islets (Masereel et al., 1997
).
The aim of the present study was to further document the effects of BM
208 and BM 225 on the secretory activity of rat pancreatic B cells. In
addition, we determined whether the capacity of the glibenclamide
isosteres to stimulate insulin release was related to changes in ionic
movements and cytosolic Ca2+ concentrations.
 |
Materials and Methods |
Animals.
All experiments were performed with pancreatic
islets isolated by the collagenase method from fed female albino rats.
Measurements of 86Rb, 45Ca Outflow, and
Insulin Release From Perifused Pancreatic Islets.
The methods used
to measure 86Rb (42K substitute) outflow,
45Ca outflow, and insulin release from perifused islets
have been described previously (Lebrun et al., 1982a
, 1985
, 1996
).
Groups of 100 islets were incubated for 60 min in a
bicarbonate-buffered medium (115 mM NaCl, 5 mM KCl, 2.56 mM
CaCl2, 1 mM MgCl2, 24 mM NaHCO3)
containing 16.7 mM glucose and either 86Rb (0.15-0.25 mM;
50 µCi/ml) or 45Ca (0.02-0.04 mM; 100 µCi/ml). After
incubation, the islets were washed four times with a nonradioactive
medium and then placed in a perifusion chamber. The perifusate was
delivered at a constant rate (1.0 ml/min). From minute 31 to min 90 of
perifusion, the effluent was continuously collected over successive
periods of 1 min each. An aliquot of the effluent (0.5 ml) was used for
scintillation counting while the remainder was stored at
20°C for
insulin radioimmunoassay (Leclercq-Meyer et al., 1985
). At the end of
the perifusion, the radioactive content of the islets was also
determined. The outflow of 86Rb or 45Ca
(cpm/min) was expressed as a fractional outflow rate (percentage of
instantaneous islet content/min; FOR). The validity of 86Rb
as a tracer for the study of K+ handling in the islets has
been previously assessed (Malaisse et al., 1978
).
Patch-Clamp Measurements.
All electrophysiological studies
were performed on primary cultured rat islet cells prepared as
described previously (Findlay et al., 1985
). Cells were maintained
using standard tissue culture conditions for 18 to 72 h in RPMI
1640 medium (GIBCO, UK) supplemented with 10% FCS and 100 IU/0.1 mg/ml
penicillin/streptomycin, respectively. Single-channel currents were
recorded using the cell-free, inside-out patch-clamp configuration
(Hamill et al., 1981
). Micropipettes were filled with an
Na+-rich solution of the following ionic composition: 140 mM NaCl, 4.7 mM KCl, 1.13 mM MgCl2, 2.5 mM
CaCl2, 2.5 mM glucose, 10 mM HEPES, pH 7.4. The internal
face of membrane was bathed with a K+-rich solution
containing 140 mM KCl, 10 mM NaCl, 1.13 mM MgCl2, 1 mM
EGTA, 2.5 mM glucose, and 10 mM HEPES, pH 7.2. Unitary current events
from KATP+ channels were recorded at 0-mV
voltage-clamp. Under these experimental conditions, with the
intracellular Ca2+ buffered to below 10 nM, openings of
Ca2+- and voltage-gated K+ channels were not
observed (Harding et al., 1994
; Lebrun et al., 1996
). Experimental data
were stored on digital tape for subsequent replay and analysis.
Modulation of KATP+ channels was described in terms of
a change in the channel open-state probability. These values were
quantified from prerecorded stretches of data lasting between 30 and
40 s and were expressed as a fraction of the immediate precontrol
value (Lebrun et al., 1996
).
Recovery values were obtained under steady-state conditions, generally
between 2 and 3 min after removal of drugs.
Measurements of Fura-2 Fluorescence From Single Islet
Cells.
Pancreatic islets were disrupted in a
Ca2+-deprived medium and then centrifuged through an
albumin solution to remove debris and dead cells. Cells were seeded
onto glass coverslips and maintained in tissue culture for 72 h.
Islet cells were cultured in RPMI 1640 medium (GIBCO) supplemented with
10% newborn calf serum and containing penicillin (100 IU/ml) and
streptomycin (0.1 mg/ml). The cells were then incubated with the
fluorescent Ca2+ indicator fura-2 AM (2 µM) for 1 h,
and after washing, the coverslips with the cells were mounted as the
bottom of an open chamber (1 ml) placed on the stage of the microscope.
The medium used to perfuse the cells contained 115 mM NaCl, 5 mM KCl,
2.56 mM CaCl2, 1 mM MgCl2, 24 mM
NaHCO3, and 2.8 mM glucose, and was gassed with 95%
O2/5% CO2. fura-2 Fluorescence of
single-loaded cells was measured by use of dual-excitation
microfluorimetry with a Spex photometric system (Optilas, Alphen aan
den Rijn, Holland). The excitation and emission wavelengths were set at
340/380 and 510 nm, respectively. [Ca2+]i was
calculated as described previously (Lebrun et al., 1996
). Individual
experiments were repeated at least four times, on different cell populations.
Drugs.
In some experiments, extracellular Ca2+
was eliminated by the omission of CaCl2 from the
physiological medium and the addition of 0.5 mM EGTA (Sigma Chemical
Co., St. Louis, MO). The medium also contained (as required) glucose
(Merck, Darmstadt, Germany), glibenclamide (Hoechst Roussel, Belgium),
verapamil hydrochloride (Knoll A.G., Germany), BM 208, and BM 225. BM
208 and BM 225 were synthesized at the Department of Medicinal
Chemistry, University of Liège, Belgium. Purity and stability
were checked by thin-layer chromatography and elemental analyses (C, H,
N, S). Both drugs were revealed to be stable compounds as powders as
well as in solution. Glibenclamide, BM 208, and BM 225 were dissolved
in dimethyl sulfoxide, which was added to both control and test media at final concentrations not exceeding 0.1% (v/v). At this
concentration, dimethyl sulfoxide fails to affect islet function
(Lebrun and Atwater, 1985
; Lebrun et al., 1996
).
Calculations.
Results are expressed as the mean ± S.E.M. The basal value for 86Rb, 45Ca outflow,
or insulin release was computed from minute 40 to 44 of perifusion
inclusive. The inhibitory effect of drugs on 86Rb outflow
was taken as the difference between the mean value for 86Rb
outflow recorded in each individual experiment between the 40 and 44 min and 60 and 68 min of perifusion. The magnitude of the increase in
86Rb, 45Ca outflow, or insulin release was
estimated in each individual experiment from the integrated outflow of
86Rb, 45Ca, or insulin release observed during
stimulation (minute 45 to 68) after correction for basal value (40-44
min). The statistical significance of differences between mean data was
assessed by using Student's t test.
 |
Results |
Effects of BM 208 and BM 225 on 86Rb, 45Ca
Outflow, and Insulin Release From Perifused Rat Pancreatic Islets.
BM 208 (10 µM) and BM 225 (10 µM) provoked a rapid and sustained
inhibition of 86Rb outflow from pancreatic islets perifused
throughout in the presence of 2.8 mM glucose and extracellular
Ca2+ (Fig. 2, top). The
capacity of 10 µM BM 208 and 10 µM BM 225 to inhibit the
86Rb outflow rate was identical. Thus, the paired
difference in 86Rb FOR before (minute 40-44) and during
(minute 60-68) exposure to the drugs averaged 1.83 ± 0.10 %/min
after the addition of BM 208 and 2.00 ± 0.09 %/min after the
addition of BM 225 (P > .05). The inhibitory effect of
BM 208 on 86Rb FOR was slowly reversible, whereas the
latter effect persisted for at least 20 min after removal of BM 225 from the perifusate.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of BM 208 (10 µM; ) and BM 225 (10 µM;
) on 86Rb (top), 45Ca outflow (middle), and
insulin release (bottom) from perifused pancreatic islets. Basal media
contained 2.8 mM glucose and extracellular Ca2+. Mean
values (±S.E.) refer to five to eight individual experiments.
|
|
In the presence of 2.8 mM glucose and extracellular Ca2+,
the addition of 10 µM BM 208 induced a marginal and slowly reversible increase in 45Ca outflow (Fig. 2, middle). By contrast, 10 µM BM 225 provoked a marked, sustained and reversible enhancement of
45Ca outflow (Fig. 2, middle).
Under the same experimental conditions, 10 µM BM 208 only caused a
short-lasting stimulation of insulin release whereas 10 µM BM 225 markedly increased insulin output (Fig. 2, bottom).
In a second set of experiments, we characterized the effects of a
higher concentration (25 µM) of BM 208 and BM 225 on
86Rb, 45Ca outflow, and insulin release from
pancreatic islets perifused throughout in the presence of 2.8 mM
glucose (Fig. 3). The addition of BM 208 (25 µM) or BM 225 (25 µM) markedly reduced 86Rb FOR
(Fig. 3, top). As mentioned above, the inhibitory effect of BM 208 was
similar to that of BM 225. Thus, the paired difference in
86Rb FOR before (minute 40-44) and during (minute 60-68)
exposure to the drugs averaged 2.24 ± 0.16%/min after exposure
to BM 208 and 1.95 ± 0.13 %/min after exposure to BM 225 (P > .05). BM 225, however, evoked a more abrupt and
less readily reversible cationic response (Fig. 3, compare top right
and top left).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of BM 208 (25 µM; left) and BM 225 (25 µM; right) on 86Rb (top), 45Ca outflow
(middle), and insulin release (bottom) from perifused pancreatic
islets. Basal media contained 2.8 mM glucose and extracellular
Ca2+ ( ) or 2.8 mM glucose without extracellular
Ca2+ ( ). Mean values (±S.E.) refer to four to six
individual experiments.
|
|
Under the same experimental conditions, namely, in the presence of
extracellular Ca2+ and 2.8 mM glucose in the medium, both
BM 208 and BM 225 increased the rate of 45Ca outflow (Fig.
3, middle). The stimulatory effect of BM 225 was more marked than that
of BM 208 (Fig. 3, middle, and Table 1).
View this table:
[in this window]
[in a new window]
|
TABLE 1
Effects of Glibenclamide, BM 208, and BM 225 on 45Ca Outflow
and Insulin Output From Perifused Rat Pancreatic Islets
|
|
Incidentally, the magnitude of the stimulatory effect of BM 225 on
45Ca outflow was significantly more pronounced at a 25 µM
(1.185 ± 0.042 %/min) than at a 10 µM concentration
(0.815 ± 0.106 %/min; P < .05).
When the same experiment was repeated in the absence of extracellular
Ca2+, the addition of BM 208 (25 µM) or BM 225 (25 µM)
failed to affect the 45Ca FOR (Fig. 3, middle).
In islets exposed throughout to 2.8 mM glucose and extracellular
Ca2+, BM 208 (25 µM) elicited a modest stimulation of
insulin release (Fig. 3, bottom). On removal of the drug from the
perfusate, a decrease in the insulin secretory rate was noticed. Under
the same experimental conditions, BM 225 (25 µM) provoked a more
pronounced stimulation of insulin output (Fig. 3, bottom, and Table 1). Moreover, the 45Ca and the secretory responses to BM 208 were clearly reversible phenomena. By contrast, even 20 min after the
removal of BM 225 from the perifusate, the 45Ca outflow
rate and the output of insulin remained higher than their initial
values (Fig. 3, middle and bottom). Last, compared with glibenclamide
(25 µM), BM 225 (25 µM) appeared as potent as the reference
molecule at increasing 45Ca outflow and insulin release
from pancreatic islets perifused throughout in the presence of 2.8 mM
glucose and extracellular Ca2+ (Table 1). Incidentally, for
all drugs tested, a close relationship between the magnitude of the
cationic and secretory events was noticed (Table 1).
Effects of BM 208 and BM 225 on Individual KATP+
Channel Events.
The effects of the glibenclamide isosters were
further characterized using the inside-out configuration of the
patch-clamp technique. As described previously (Harding et al. 1994
;
Lebrun et al., 1996
), the addition of ATP (1 mM) on the inside
face of the B cell membrane inhibited K+ channel activity
(Fig. 4A). Removal of ATP was followed by
an immediate increase in KATP+ channel opening.
Under these experimental conditions (no ATP in the bathing medium), the
addition of BM 208 (25 µM) inhibited KATP+ channel
activity (Fig. 4A). Similar effects were noticed with BM 225 (25 µM;
Fig. 4B). A quantitative analysis revealed that the
KATP+ channel open-state probability averaged 17.7 ± 3.6% after the addition of BM 208 (P < .05) and
24.7 ± 6.1% after addition of BM 225 (P < .05)
(Fig. 4C). The effects of BM 208 and BM 225 were sustained and not
readily reversible (Fig. 4C).

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of BM 208 and BM 225 on
KATP+ channels. Data were obtained at 0 mV
voltage-clamp with upward deflections from the base line representing
outward currents. A, effect of the addition and removal of either ATP
(1 mM) or BM 208 (25 µM). B, data from the same patch recorded before
(top), during the application of BM 225 (25 µM; middle), and after
removal of the drug (bottom). C, quantitative analysis of the effects
of BM 208 (25 µM) and BM 225 (25 µM) on KATP+
channels. The third column refers, in each case, to recovery values.
Average values (±S.E.) from six patches in each case.
|
|
Effects of BM 208 and BM 225 on Intracellular Ca2+
Concentration.
Both BM 208 (25 µM) and BM 225 (25 µM)
increased the fluorescence intensity of fura-2-loaded islet cells
perifused in the presence of 2.8 mM glucose (Fig.
5). Although the addition of BM 208 or BM
225 caused an immediate 2-fold increase in cytosolic Ca2+
concentration, the effect of BM 208 declined rapidly, whereas the
enhancing effect of BM 225 was more sustained (Fig.
5). After the addition of BM 225 (25 µM), the initial peak of intracellular Ca2+
concentration ([Ca2+]i) was followed by a
slowly declining plateau that was higher than prestimulation values and
was maintained for at least 10 min (Fig. 5, right).

View larger version (7K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of BM 208 (25 µM; left) and BM 225 (25 µM;
right) on the cytosolic Ca2+ concentration of single
pancreatic B cells. Basal media contained 2.8 mM glucose and
extracellular Ca2+. Each graph is a representative
experiment conducted on a single cell.
|
|
In the next series of experiments, we characterized the effect of
verapamil on the BM 208- and BM 225-induced rise in cytosolic Ca2+ concentration (Fig. 6).
Verapamil, a Ca2+ entry blocker, is known to provoke an
immediate and sustained decrease in [Ca2+]i
in glucose-stimulated islet cells (Lebrun et al., 1997
).

View larger version (7K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of verapamil (50 µM) on BM 208 (25 µM;
left) and BM 225 (25 µM; right)-induced increases in cytosolic
Ca2+ concentration. Basal media contained 2.8 mM glucose
and extracellular Ca2+. Each graph is a representative
experiment conducted on a single cell.
|
|
Because BM 208 caused a nonsustained increase in
[Ca2+]i, verapamil (50 µM) was added 3 min
after the BM 208 (25 µM) stimulus. The addition of verapamil provoked
an abrupt decay in the cellular fluorescence (Fig. 6, left). When
verapamil (50 µM) was added during the plateau phase of the BM 225 (25 µM) response, a rapid decrease in
[Ca2+]i was also noticed (Fig. 6, right).
 |
Discussion |
Our data indicate that at a low glucose concentration (2.8 mM), BM 208 and BM 225 cause a sustained decrease in 86Rb
outflow from prelabeled and perifused rat pancreatic islets. This
feature is reminiscent of the inhibitory effect of hypoglycemic sulfonylureas on 86Rb FOR and is compatible with the view
that the newly synthesized isosteres of glibenclamide provoke the
closure of KATP+ channels (Malaisse and Lebrun, 1990
;
Lebrun and Malaisse, 1992
). Such an hypothesis was confirmed by single
patch-clamp recordings that revealed that BM 208 and BM 225 reduced
KATP+ channel open-state probability. By either
directly measuring K+ channel activity or by monitoring
86Rb outflow, we found that the actions of both compounds
were poorly reversible. This feature is reminiscent of the previously
reported effects of glibenclamide (Malaisse and Lebrun, 1990
; Lebrun
and Malaisse, 1992
).
The inhibition of 86Rb outflow brought about by BM
208 and BM 225 coincided with an increase in 45Ca outflow.
The latter phenomenon was abolished in islets exposed to
Ca2+-free medium. Thus, the BM-induced increases in
45Ca outflow are likely to reflect a stimulation of
40Ca inflow into the islet cells with resulting release of
labeled 45Ca from intracellular sites (Lebrun et al.,
1982a
, b
). The ability of BM 208 and BM 225 to enhance Ca2+
entry is substantiated by the observation that both compounds increase
the [Ca2+]i in islet cells incubated under
the same experimental conditions. Moreover, the BM-induced increases in
[Ca2+]i were reduced by verapamil; a
phenylalkylamine Ca2+ entry blocker (Lebrun et al., 1982a
,
1997
; Godfraind et al., 1986
; Plasman et al., 1991
).
At first glance, these results recorded at a low concentration of
D-glucose would suggest that the newly synthesized
isosteres of glibenclamide decrease K+ permeability by
closing KATP+ channels, depolarize the plasma membrane,
activate the voltage-sensitive Ca2+ channels, increase
Ca2+ inflow, and, eventually, promote insulin release.
However, a closer examination of the data revealed further features of
the cationic and secretory responses to glibenclamide isosteres.
Indeed, BM 208 and BM 225 inhibited 86Rb outflow and
KATP+ current to the same extent, whereas the
stimulatory effect of BM 225 on 45Ca outflow,
[Ca2+]i, and insulin output was more marked
than that of BM 208. Moreover, for both compounds, a poor reversibility
of the 86Rb response contrasted with a more or less rapid
return of 45Ca outflow rate and insulin release to basal
values. Taken as a whole, these data suggest that the BM-induced
inhibition of KATP+ channels cannot fully account for
the modifications in Ca2+ inflow and insulin output.
Although a distal effect in the sequence of events leading to insulin
release cannot be absolutely excluded (Eliasson et al., 1996
), it is
more likely that the insulinotropic effect of the new compounds is
attributable to their capacity to affect transmembrane Ca2+ movements.
Different KATP+-independent modalities can be
considered to account, at least in part, for the BM-induced
Ca2+ inflow across the B cell membrane. It can be
hypothesized that the bioisosteres of glibenclamide facilitate
Ca2+ inflow through voltage-insensitive Ca2+
channels. Previous studies indeed suggested that the B cell might be
equipped with a voltage-insensitive pathway of Ca2+ entry
(Lebrun et al., 1982a
; Rojas et al., 1990
). Alternatively, and perhaps
more likely, it is conceivable that part of the effect of BM compounds
on Ca2+ inflow might correspond to a drug-induced
facilitation of Ca2+ transport as mediated by an
ionophoretic process. This interpretation is consistent with the
knowledge that hypoglycemic sulfonylureas may behave as ionophoretic
agents and enhance an ionophoretic modality of Ca2+
transport across the B cell plasma membrane (Couturier and Malaisse, 1980
). Incidentally, the latter effects can be inhibited by organic compounds such as verapamil (Couturier and Malaisse, 1980
; Malaisse et
al., 1981
). Thus, the demonstration of an inhibitory effect of
verapamil on the BM-induced increases in
[Ca2+]i could also support the idea that the
BM isosteres mediate an ionophoretic modality of Ca2+
inflow (Lebrun et al., 1982b
). Last, this ionophoretic hypothesis is
also supported by the finding that BM 225 was more potent than BM 208 at increasing Ca2+ inflow. Indeed, the more pronounced
effect of BM 225 on Ca2+ movements coincides with its
higher capacity to penetrate the plasma membrane (Masereel et al.,
1997
).
In conclusion, the present study indicates that two newly synthesized
isosteres of glibenclamide provoke a concentration-dependent increase
in insulin output from pancreatic islets perifused at low glucose
concentration (2.8 mM). Under these experimental conditions, the
secretory capacity of BM 225 was more marked than that of BM 208. The
stimulation of insulin release induced by both compounds results, at
least in part, from the inhibition of KATP+ channels
with subsequent opening of voltage-sensitive Ca2+ channels.
The work further reveals that the time courses of the cationic, in
terms of 86Rb outflow and 45Ca outflow, and
secretory responses exhibited obvious dissociations. Such features
suggest that the modifications in Ca2+ handling induced by
the glibenclamide bioisosteres are not exclusively dependent on changes
in the activity of the KATP+ channels. It is speculated
that the insulinotropic action of both compounds could also be
mediated, at least in part, by a Ca2+ ionophoretic process.
We are indebted to J. Sergooris, M. Hermann for technical
assistance, and to P. Surardt for secretarial help.
Accepted for publication November 24, 1998.
Received for publication November 24, 1998.